Search results for Tilavonemab

Tilavonemab Biosimilar – Research Grade mAb, ProteoGenix, PX-TA1404-

Tilavonemab, Abbexa, abx831363

Tilavonemab is a monoclonal antibody biosimilar expressed in CHO cells, targeting MAPT, for use in laboratory research applications. This product is not suitable for use as medicines or in human, therapeutic or diagnostic applications.

Tilavonemab ELISA Kit, Abbexa, abx395057

Tilavonemab ELISA Kit is a quantitative ELISA kit for detection of Tilavonemab.Tilavonemab (ABBV-8E12) is an antibody recognizing the aggregated, extracellular form of pathological tau and binding to the N-terminus of tau. This drug was developed by C2N Diagnostics and AbbVie and has been validated for its safety in a phase I trial. However, the phase II trial, evaluating the efficacy and safety of tilavonemab in 453 patients with early AD, did not obtain expected results and now tilavonemab is discontinued in AD treatment. In addition, a phase II trial purposed to assess the long-term safety and tolerability of tilavonemab in 364 participants with early AD was finished in September 30, 2021, but its final reports are not available.

Tilavonemab ELISA Kit, ProteoGenix, KPTX168

Description of Tilavonemab ELISA Kit Introduction to Tilavonemab ELISA Kit The use of antibodies as therapeutic targets has revolutionized the field of medicine, providing new and effective treatment options for a wide range of diseases. One such antibody, Tilavonemab, has recently gained attention for its potential in treating inflammatory diseases. In this article, we will explore the structure, activity, and application of Tilavonemab ELISA Kit, a powerful tool for detecting and quantifying Tilavonemab levels in biological samples. Structure of Tilavonemab Tilavonemab is a humanized monoclonal antibody, meaning it is derived from human cells and has been modified to specifically target a certain molecule or protein. It is designed to bind to and neutralize the activity of a protein called IL-17A, which is involved in the inflammatory response. The antibody is composed of two heavy chains and two light chains, each with a unique sequence of amino acids that determine its specificity and binding affinity. Activity of Tilavonemab Tilavonemab works by binding to IL-17A, preventing it from interacting with its receptors on immune cells. This inhibits the production of pro-inflammatory cytokines, which are responsible for causing inflammation in various diseases such as psoriasis, rheumatoid arthritis, and inflammatory bowel disease. By blocking IL-17A, Tilavonemab helps to reduce inflammation and alleviate symptoms in these conditions. Title: The Role of Tilavonemab ELISA Kit The detection and quantification of Tilavonemab levels in biological samples is crucial for monitoring its activity and effectiveness in patients. This is where Tilavonemab ELISA Kit comes into play. ELISA stands for Enzyme-Linked Immunosorbent Assay, and it is a widely used technique for detecting and measuring the concentration of a specific molecule in a sample. In this case, the molecule of interest is Tilavonemab. Title: How Tilavonemab ELISA Kit Works Tilavonemab ELISA Kit utilizes the specific binding between Tilavonemab and IL-17A to detect and quantify the antibody in biological samples. The kit contains pre-coated plates with IL-17A, which acts as the capture antigen. The sample, whether it is serum, plasma, or tissue lysate, is added to the plate and any Tilavonemab present in the sample will bind to the IL-17A. After washing away any unbound material, a secondary antibody is added, which recognizes and binds to Tilavonemab. This secondary antibody is linked to an enzyme, which produces a color change when a substrate is added. The intensity of the color is directly proportional to the amount of Tilavonemab present in the sample, allowing for accurate quantification. Title: Applications of Tilavonemab ELISA Kit The Tilavonemab ELISA Kit has a wide range of applications in both research and clinical settings. In research, it is used to measure Tilavonemab levels in preclinical studies, helping to determine the appropriate dosage for clinical trials. In clinical settings, it is used to monitor Tilavonemab levels in patients receiving treatment, ensuring they are receiving the correct dose and assessing the effectiveness of the therapy. The kit can also be used to screen for the presence of Tilavonemab in blood donations, as it may interfere with the immune response in recipients. In conclusion, Tilavonemab ELISA Kit is a valuable tool for detecting and quantifying Tilavonemab levels in biological samples. Its structure and activity make it a promising therapeutic target for inflammatory diseases, and its application in research and clinical settings makes it an essential tool for studying and monitoring the effects of this antibody.

Tilavonemab Biosimilar - Research Grade, ichor.bio, ICH5125

Detects human MAPT

Research Grade Tilavonemab (HY086036), abinScience, HY086036